d42224fb073c33725fae3ba47fa5b4b4e8d5b8ac
DLBCL_genes_with_bib.md
| ... | ... | @@ -0,0 +1,756 @@ |
| 1 | +# DLBCL genes |
|
| 2 | + |
|
| 3 | +| Gene | Tier | DLBCL Reference | Other references | |
|
| 4 | +|:---------:|:----:|:------------------------------------------------:|:-----------------------------:| |
|
| 5 | +| ABI3BP | 2 | (Morin et al. 2013) | | |
|
| 6 | +| ACTB | 1 | (Lohr et al. 2012) | | |
|
| 7 | +| ACTG1 | 1 | (Hübschmann et al. 2021) | | |
|
| 8 | +| ADAMTS1 | 2 | (Hübschmann et al. 2021) | | |
|
| 9 | +| AICDA | 2 | (Arthur et al. 2018) | | |
|
| 10 | +| ANKRD12 | 2 | (Hübschmann et al. 2021) | | |
|
| 11 | +| ANKRD17 | 2 | (Reddy et al. 2017) | | |
|
| 12 | +| ARID1A | 1 | (Zhang et al. 2013) | (Krysiak et al. 2017) | |
|
| 13 | +| ARID1B | 2 | (Reddy et al. 2017) | | |
|
| 14 | +| ARID5B | 2 | (Reddy et al. 2017) | | |
|
| 15 | +| ATM | 1 | (Reddy et al. 2017) | | |
|
| 16 | +| ATR | 2 | (Reddy et al. 2017) | | |
|
| 17 | +| B2M | 1 | (Morin et al. 2011) | | |
|
| 18 | +| BCL10 | 1 | (Morin et al. 2011) | (Russler-Germain et al. 2023) | |
|
| 19 | +| BCL11A | 1 | | | |
|
| 20 | +| BCL2 | 1 | (Tanaka et al. 1992) | (Morin et al. 2011) | |
|
| 21 | +| BCL6 | 1 | (Morin et al. 2011) | | |
|
| 22 | +| BCL7A | 1 | (Arthur et al. 2018) | (Krysiak et al. 2017) | |
|
| 23 | +| BCOR | 1 | | | |
|
| 24 | +| BCR | 1 | | | |
|
| 25 | +| BIRC3 | 2 | (Arthur et al. 2018) | | |
|
| 26 | +| BIRC6 | 1 | (Reddy et al. 2017) | | |
|
| 27 | +| BLK | 2 | | | |
|
| 28 | +| BRAF | 1 | (Tiacci et al. 2011) | | |
|
| 29 | +| BRINP3 | 2 | (Reddy et al. 2017) | | |
|
| 30 | +| BTBD3 | 2 | (Reddy et al. 2017) | | |
|
| 31 | +| BTG1 | 1 | (Morin et al. 2011) | | |
|
| 32 | +| BTG2 | 1 | (Morin et al. 2011) | | |
|
| 33 | +| BTK | 1 | (Albuquerque et al. 2017) | (Krysiak et al. 2017) | |
|
| 34 | +| CADPS2 | 2 | (Hübschmann et al. 2021) | | |
|
| 35 | +| CARD11 | 1 | (Lenz et al. 2008) | (Morin et al. 2011) | |
|
| 36 | +| CASP8 | 1 | (Reddy et al. 2017) | | |
|
| 37 | +| CBLB | 2 | (Reddy et al. 2017) | | |
|
| 38 | +| CCL4 | 2 | (Chapuy et al. 2018) | | |
|
| 39 | +| CCND3 | 1 | (Morin et al. 2011) | | |
|
| 40 | +| CD22 | 2 | (Reddy et al. 2017) | | |
|
| 41 | +| CD274 | 1 | (Morin et al. 2011) | | |
|
| 42 | +| CD36 | 1 | (Laura Pasqualucci, Trifonov, et al. 2011) | | |
|
| 43 | +| CD44 | 2 | (Arthur et al. 2018) | | |
|
| 44 | +| CD58 | 1 | (Morin et al. 2011) | | |
|
| 45 | +| CD70 | 1 | (Morin et al. 2011) | (Russler-Germain et al. 2023) | |
|
| 46 | +| CD74 | 2 | (Arthur et al. 2018) | | |
|
| 47 | +| CD79B | 1 | (Morin et al. 2011) | | |
|
| 48 | +| CD83 | 1 | (Morin et al. 2013) | (Russler-Germain et al. 2023) | |
|
| 49 | +| CDC73 | 2 | (Reddy et al. 2017) | | |
|
| 50 | +| CDH9 | 2 | (Morin et al. 2013) | | |
|
| 51 | +| CDKN2A | 1 | (Morin et al. 2013) | | |
|
| 52 | +| CHD1 | 2 | (Reddy et al. 2017) | | |
|
| 53 | +| CHD8 | 2 | (Reddy et al. 2017) | | |
|
| 54 | +| CHST2 | 2 | (Reddy et al. 2017) | | |
|
| 55 | +| CIITA | 1 | (Morin et al. 2011) | | |
|
| 56 | +| CNOT2 | 2 | (Hübschmann et al. 2021) | | |
|
| 57 | +| CNTNAP5 | 2 | (Morin et al. 2013) | | |
|
| 58 | +| COQ7 | 2 | (Chapuy et al. 2018) | | |
|
| 59 | +| CREBBP | 1 | (Laura Pasqualucci, Dominguez-Sola, et al. 2011) | | |
|
| 60 | +| CRIP1 | 2 | (Chapuy et al. 2018) | | |
|
| 61 | +| CXCR4 | 1 | (Khodabakhshi et al. 2012) | (Krysiak et al. 2017) | |
|
| 62 | +| CXCR5 | 1 | (Schmitz et al. 2018) | | |
|
| 63 | +| DAZAP1 | 1 | (Pararajalingam et al. 2020) | | |
|
| 64 | +| DCAF6 | 2 | (Reddy et al. 2017) | | |
|
| 65 | +| DDX10 | 2 | (Reddy et al. 2017) | | |
|
| 66 | +| DDX3X | 1 | (Schmitz et al. 2018) | | |
|
| 67 | +| DHX16 | 2 | (Hübschmann et al. 2021) | | |
|
| 68 | +| DICER1 | 2 | (Reddy et al. 2017) | | |
|
| 69 | +| DNAH5 | 2 | (Morin et al. 2013) | | |
|
| 70 | +| DNM2 | 2 | (Hübschmann et al. 2021) | | |
|
| 71 | +| DNMT3A | 2 | (Reddy et al. 2017) | | |
|
| 72 | +| DOCK1 | 2 | (Chapuy et al. 2018) | | |
|
| 73 | +| DSG4 | 2 | (Morin et al. 2013) | | |
|
| 74 | +| DTX1 | 1 | (Schmitz et al. 2018) | | |
|
| 75 | +| DUSP2 | 1 | (Morin et al. 2013) | | |
|
| 76 | +| EBF1 | 1 | (Bohle et al. 2013) | | |
|
| 77 | +| EEF1A1 | 1 | (Hübschmann et al. 2021) | | |
|
| 78 | +| EIF2AK3 | 2 | | | |
|
| 79 | +| EP300 | 1 | (Laura Pasqualucci, Dominguez-Sola, et al. 2011) | | |
|
| 80 | +| ETS1 | 1 | (Morin et al. 2011) | | |
|
| 81 | +| ETV6 | 1 | (Arthur et al. 2018) | | |
|
| 82 | +| EZH2 | 1 | (Morin et al. 2010) | | |
|
| 83 | +| EZR | 2 | | | |
|
| 84 | +| FAM102A | 2 | | | |
|
| 85 | +| FAM38B | 2 | (Morin et al. 2013) | | |
|
| 86 | +| FANK1 | 2 | | | |
|
| 87 | +| FAS | 1 | (Scholl et al. 2007) | | |
|
| 88 | +| FAT4 | 2 | (Morin et al. 2013) | | |
|
| 89 | +| FBXO11 | 1 | (Hübschmann et al. 2021) | | |
|
| 90 | +| FBXW7 | 1 | (Zhang et al. 2013) | | |
|
| 91 | +| FCRL3 | 2 | | | |
|
| 92 | +| FNBP1 | 2 | | | |
|
| 93 | +| FNDC1 | 2 | (Morin et al. 2013) | | |
|
| 94 | +| FOXC1 | 1 | (Schmitz et al. 2018) | | |
|
| 95 | +| FOXO1 | 1 | (Morin et al. 2011) | | |
|
| 96 | +| FOXP1 | 2 | (Reddy et al. 2017) | | |
|
| 97 | +| FUBP1 | 2 | (Reddy et al. 2017) | | |
|
| 98 | +| FUT5 | 2 | (Chapuy et al. 2018) | | |
|
| 99 | +| GABRA2 | 2 | (Chapuy et al. 2018) | | |
|
| 100 | +| GAK | 2 | (Hübschmann et al. 2021) | | |
|
| 101 | +| GNA13 | 1 | (Morin et al. 2011) | | |
|
| 102 | +| GNAI2 | 1 | (Morin et al. 2013) | | |
|
| 103 | +| GNAS | 2 | (Reddy et al. 2017) | | |
|
| 104 | +| GOLGA5 | 2 | (Reddy et al. 2017) | | |
|
| 105 | +| GPC5 | 2 | (Schmitz et al. 2018) | | |
|
| 106 | +| GRB2 | 1 | (Laura Pasqualucci, Trifonov, et al. 2011) | | |
|
| 107 | +| GRHPR | 1 | (Arthur et al. 2018) | | |
|
| 108 | +| GSG2 | 2 | (Schmitz et al. 2018) | | |
|
| 109 | +| HDAC7 | 2 | (Morin et al. 2013) | | |
|
| 110 | +| HIST1H1B | 1 | (Chapuy et al. 2018) | (Krysiak et al. 2017) | |
|
| 111 | +| HIST1H1C | 1 | (Morin et al. 2011) | | |
|
| 112 | +| HIST1H1D | 1 | (Morin et al. 2013) | (Krysiak et al. 2017) | |
|
| 113 | +| HIST1H1E | 1 | (Morin et al. 2013) | (Krysiak et al. 2017) | |
|
| 114 | +| HIST1H2AC | 1 | (Morin et al. 2013) | (Krysiak et al. 2017) | |
|
| 115 | +| HIST1H2AG | 2 | (Morin et al. 2013) | (Krysiak et al. 2017) | |
|
| 116 | +| HIST1H2AM | 1 | | (Krysiak et al. 2017) | |
|
| 117 | +| HIST1H2BC | 1 | (Reddy et al. 2017) | (Krysiak et al. 2017) | |
|
| 118 | +| HIST1H2BK | 1 | | | |
|
| 119 | +| HIST1H3B | 1 | (Zhang et al. 2013) | | |
|
| 120 | +| HIST2H2BE | 1 | (Schmitz et al. 2018) | | |
|
| 121 | +| HLA-A | 1 | | | |
|
| 122 | +| HLA-B | 1 | | | |
|
| 123 | +| HLA-C | 1 | | | |
|
| 124 | +| HLA-DMA | 1 | | | |
|
| 125 | +| HLA-DMB | 1 | | | |
|
| 126 | +| HLA-DQA1 | 1 | (Hübschmann et al. 2021) | | |
|
| 127 | +| HNF1B | 2 | (Laura Pasqualucci, Trifonov, et al. 2011) | | |
|
| 128 | +| HNRNPD | 1 | | | |
|
| 129 | +| HNRNPH1 | 1 | (Pararajalingam et al. 2020) | | |
|
| 130 | +| HNRNPU | 1 | (Reddy et al. 2017) | | |
|
| 131 | +| HRAS | 2 | (Reddy et al. 2017) | | |
|
| 132 | +| HVCN1 | 1 | | (Krysiak et al. 2017) | |
|
| 133 | +| ID3 | 2 | (Schmitz et al. 2012) | | |
|
| 134 | +| IER2 | 2 | (Morin et al. 2013) | | |
|
| 135 | +| IFNGR1 | 2 | (Morin et al. 2013) | | |
|
| 136 | +| IGLL5 | 2 | | (Russler-Germain et al. 2023) | |
|
| 137 | +| IKBKB | 2 | (Reddy et al. 2017) | | |
|
| 138 | +| IKBKE | 2 | (Hübschmann et al. 2021) | | |
|
| 139 | +| IKZF3 | 1 | (Morin et al. 2013) | | |
|
| 140 | +| IL16 | 1 | | | |
|
| 141 | +| IL4R | 1 | (Duns et al. 2021) | | |
|
| 142 | +| IL6 | 2 | (Chapuy et al. 2018) | | |
|
| 143 | +| INO80 | 2 | (Zhang et al. 2013) | | |
|
| 144 | +| IRAG2 | 2 | | | |
|
| 145 | +| IRF1 | 2 | (Hübschmann et al. 2021) | | |
|
| 146 | +| IRF4 | 1 | (Morin et al. 2011) | | |
|
| 147 | +| IRF8 | 1 | (Morin et al. 2011) | | |
|
| 148 | +| ITPKB | 1 | (Schmitz et al. 2018) | | |
|
| 149 | +| JAK1 | 2 | (Zhang et al. 2013) | | |
|
| 150 | +| JAK3 | 2 | (Zhang et al. 2013) | | |
|
| 151 | +| JUNB | 1 | (Reddy et al. 2017) | | |
|
| 152 | +| KCMF1 | 2 | (Reddy et al. 2017) | | |
|
| 153 | +| KLF2 | 1 | (Laura Pasqualucci, Trifonov, et al. 2011) | | |
|
| 154 | +| KLHL14 | 1 | (Zhang et al. 2013) | | |
|
| 155 | +| KLHL21 | 2 | (Schmitz et al. 2018) | | |
|
| 156 | +| KLHL6 | 1 | (Morin et al. 2011) | | |
|
| 157 | +| KMT2C | 1 | (Zhang et al. 2013) | | |
|
| 158 | +| KMT2D | 1 | (Morin et al. 2011) | | |
|
| 159 | +| KRAS | 1 | (Lohr et al. 2012) | | |
|
| 160 | +| LAMA5 | 2 | (Schmitz et al. 2018) | | |
|
| 161 | +| LAPTM5 | 2 | | (Hübschmann et al. 2021) | |
|
| 162 | +| LCOR | 1 | (Arthur et al. 2018) | | |
|
| 163 | +| LIN54 | 2 | (Reddy et al. 2017) | | |
|
| 164 | +| LPP | 2 | (Arthur et al. 2018) | | |
|
| 165 | +| LRP12 | 2 | (Hübschmann et al. 2021) | | |
|
| 166 | +| LRRN3 | 2 | (Morin et al. 2013) | | |
|
| 167 | +| LTB | 1 | (Chapuy et al. 2018) | | |
|
| 168 | +| LYN | 1 | (Chapuy et al. 2018) | | |
|
| 169 | +| MAGT1 | 2 | (Reddy et al. 2017) | | |
|
| 170 | +| MALAT1 | 2 | (Arthur et al. 2018) | | |
|
| 171 | +| MAP2K1 | 2 | (Shin et al. 2015) | (Louissaint et al. 2016) | |
|
| 172 | +| MAP4K4 | 2 | (Reddy et al. 2017) | | |
|
| 173 | +| MARK1 | 2 | (Reddy et al. 2017) | | |
|
| 174 | +| MCL1 | 1 | (Reddy et al. 2017) | | |
|
| 175 | +| MECOM | 2 | (Reddy et al. 2017) | | |
|
| 176 | +| MEF2B | 1 | (Morin et al. 2011) | | |
|
| 177 | +| MEF2C | 1 | (Arthur et al. 2018) | | |
|
| 178 | +| MET | 2 | (Reddy et al. 2017) | | |
|
| 179 | +| MGA | 1 | (Zhang et al. 2013) | | |
|
| 180 | +| MIR142 | 2 | (Kwanhian et al. 2012) | | |
|
| 181 | +| MIR155HG | 2 | | | |
|
| 182 | +| MPDZ | 2 | (Morin et al. 2013) | | |
|
| 183 | +| MPEG1 | 1 | (Morin et al. 2013) | | |
|
| 184 | +| MS4A1 | 1 | (Rushton et al. 2020) | | |
|
| 185 | +| MSH2 | 2 | (Reddy et al. 2017) | | |
|
| 186 | +| MSH6 | 2 | (Reddy et al. 2017) | | |
|
| 187 | +| MTOR | 1 | (Zhang et al. 2013) | | |
|
| 188 | +| MYB | 2 | (Reddy et al. 2017) | | |
|
| 189 | +| MYBPC2 | 2 | (Schmitz et al. 2018) | | |
|
| 190 | +| MYC | 1 | (L. Pasqualucci et al. 2001) | | |
|
| 191 | +| MYD88 | 1 | (Ngo et al. 2011) | | |
|
| 192 | +| MYO1E | 2 | | | |
|
| 193 | +| MYOM2 | 1 | (Laura Pasqualucci, Trifonov, et al. 2011) | | |
|
| 194 | +| N2RF2 | 2 | (Hübschmann et al. 2021) | | |
|
| 195 | +| NANOG | 2 | (Chapuy et al. 2018) | | |
|
| 196 | +| NAV1 | 2 | (Chapuy et al. 2018) | | |
|
| 197 | +| NCOA3 | 2 | | | |
|
| 198 | +| NCOR1 | 2 | (Reddy et al. 2017) | | |
|
| 199 | +| NCOR2 | 1 | | | |
|
| 200 | +| NEAT1 | 2 | (Arthur et al. 2018) | | |
|
| 201 | +| NF1 | 2 | (Reddy et al. 2017) | | |
|
| 202 | +| NFKB1 | 1 | | | |
|
| 203 | +| NFKB2 | 2 | (Reddy et al. 2017) | | |
|
| 204 | +| NFKBIA | 1 | (Lake et al. 2009) | (Russler-Germain et al. 2023) | |
|
| 205 | +| NFKBIE | 1 | (Morin et al. 2016) | | |
|
| 206 | +| NFKBIZ | 1 | (Morin et al. 2016) | | |
|
| 207 | +| NLRC5 | 1 | | | |
|
| 208 | +| NLRP5 | 2 | (Morin et al. 2013) | | |
|
| 209 | +| NLRP8 | 2 | (Chapuy et al. 2018) | | |
|
| 210 | +| NOL9 | 1 | (Schmitz et al. 2018) | | |
|
| 211 | +| NOTCH1 | 1 | (Laura Pasqualucci, Trifonov, et al. 2011) | | |
|
| 212 | +| NOTCH2 | 1 | (Trøen et al. 2008) | | |
|
| 213 | +| ODZ3 | 2 | (Morin et al. 2013) | | |
|
| 214 | +| OSBPL10 | 1 | (Arthur et al. 2018) | | |
|
| 215 | +| P2RX5 | 2 | (Morin et al. 2013) | | |
|
| 216 | +| P2RY8 | 1 | (Lohr et al. 2012) | | |
|
| 217 | +| PAPOLG | 2 | (Schmitz et al. 2018) | | |
|
| 218 | +| PASK | 2 | (Morin et al. 2013) | | |
|
| 219 | +| PAX5 | 2 | (L. Pasqualucci et al. 2001) | | |
|
| 220 | +| PCBP1 | 1 | | | |
|
| 221 | +| PCDHB11 | 2 | (Morin et al. 2013) | | |
|
| 222 | +| PCLO | 2 | (Lohr et al. 2012) | | |
|
| 223 | +| PDE4DIP | 2 | (Chapuy et al. 2018) | | |
|
| 224 | +| PDS5B | 2 | (Morin et al. 2013) | (Hübschmann et al. 2021) | |
|
| 225 | +| PHF6 | 2 | (Reddy et al. 2017) | | |
|
| 226 | +| PIK3CD | 2 | (Reddy et al. 2017) | | |
|
| 227 | +| PIK3R1 | 2 | (Zhang et al. 2013) | | |
|
| 228 | +| PIM1 | 1 | (L. Pasqualucci et al. 2001) | | |
|
| 229 | +| PIM2 | 1 | (Arthur et al. 2018) | | |
|
| 230 | +| PKD1 | 2 | (Morin et al. 2013) | | |
|
| 231 | +| PNPO | 2 | (Hübschmann et al. 2021) | | |
|
| 232 | +| POGZ | 2 | (Morin et al. 2013) | | |
|
| 233 | +| POU2AF1 | 1 | | (Krysiak et al. 2017) | |
|
| 234 | +| POU2F2 | 1 | (Zhang et al. 2013) | (Krysiak et al. 2017) | |
|
| 235 | +| PPP1R9B | 2 | | | |
|
| 236 | +| PRDM1 | 1 | (**pasqualucciInactivationPRDM1BLIMP12006?**) | | |
|
| 237 | +| PRKCB | 2 | (Morin et al. 2013) | | |
|
| 238 | +| PRKDC | 1 | (Schmitz et al. 2018) | (Hübschmann et al. 2021) | |
|
| 239 | +| PRPS1 | 2 | (Chapuy et al. 2018) | | |
|
| 240 | +| PTEN | 1 | | | |
|
| 241 | +| PTMA | 2 | | | |
|
| 242 | +| PTPN1 | 2 | | | |
|
| 243 | +| PTPN23 | 2 | (Morin et al. 2013) | | |
|
| 244 | +| PTPN6 | 2 | (Reddy et al. 2017) | | |
|
| 245 | +| PTPRD | 1 | | | |
|
| 246 | +| PTPRK | 2 | (Reddy et al. 2017) | | |
|
| 247 | +| RAC2 | 2 | (Hübschmann et al. 2021) | | |
|
| 248 | +| RAD9A | 2 | (Chapuy et al. 2018) | | |
|
| 249 | +| RARA | 2 | (Reddy et al. 2017) | | |
|
| 250 | +| RB1 | 1 | (Morin et al. 2013) | | |
|
| 251 | +| RCC | 2 | | | |
|
| 252 | +| RFTN1 | 2 | (Arthur et al. 2018) | | |
|
| 253 | +| RFX7 | 1 | | | |
|
| 254 | +| RFXAP | 1 | | | |
|
| 255 | +| RHEX | 2 | | | |
|
| 256 | +| RHOA | 1 | (L. Pasqualucci et al. 2001) | | |
|
| 257 | +| RHOH | 2 | | | |
|
| 258 | +| RRAGC | 1 | (Okosun et al. 2016) | | |
|
| 259 | +| RUBCNL | 2 | | | |
|
| 260 | +| RUNX1 | 2 | (Reddy et al. 2017) | | |
|
| 261 | +| S1PR2 | 1 | (Morin et al. 2011) | | |
|
| 262 | +| SAMD9L | 2 | (Morin et al. 2013) | | |
|
| 263 | +| SARM1 | 2 | (Morin et al. 2013) | | |
|
| 264 | +| SEL1L3 | 2 | | | |
|
| 265 | +| SEPTIN9 | 2 | | | |
|
| 266 | +| SERPINA9 | 2 | (Arthur et al. 2018) | | |
|
| 267 | +| SETD1B | 1 | (Reddy et al. 2017) | | |
|
| 268 | +| SETD2 | 2 | (Zhang et al. 2013) | | |
|
| 269 | +| SETD5 | 2 | (Reddy et al. 2017) | | |
|
| 270 | +| SF3B1 | 1 | | | |
|
| 271 | +| SGK1 | 1 | (Morin et al. 2011) | | |
|
| 272 | +| SIAH2 | 2 | (Hübschmann et al. 2021) | | |
|
| 273 | +| SIN3A | 1 | | | |
|
| 274 | +| SLC34A2 | 2 | (Hübschmann et al. 2021) | | |
|
| 275 | +| SMARCA4 | 1 | (Zhang et al. 2013) | (Krysiak et al. 2017) | |
|
| 276 | +| SMEK1 | 2 | (Chapuy et al. 2018) | | |
|
| 277 | +| SOCS1 | 1 | (Morin et al. 2011) | | |
|
| 278 | +| SPEN | 1 | (Rossi et al. 2012) | | |
|
| 279 | +| SRRM2 | 2 | (Morin et al. 2013) | (Russler-Germain et al. 2023) | |
|
| 280 | +| ST6GAL1 | 2 | (Arthur et al. 2018) | | |
|
| 281 | +| STAT3 | 1 | (Ohgami et al. 2014) | | |
|
| 282 | +| STAT5B | 2 | (Zhang et al. 2013) | | |
|
| 283 | +| STAT6 | 1 | (Yildiz et al. 2015) | | |
|
| 284 | +| SYK | 2 | (Reddy et al. 2017) | | |
|
| 285 | +| SYPL1 | 2 | (Morin et al. 2013) | | |
|
| 286 | +| TAF1 | 1 | (Morin et al. 2013) | | |
|
| 287 | +| TAP1 | 2 | (Schmitz et al. 2018) | | |
|
| 288 | +| TBC1D4 | 2 | (Arthur et al. 2018) | | |
|
| 289 | +| TBL1XR1 | 1 | (Mareschal et al. 2016) | | |
|
| 290 | +| TCL1A | 2 | | | |
|
| 291 | +| TET2 | 1 | (Albuquerque et al. 2017) | | |
|
| 292 | +| TGFBR2 | 2 | (Reddy et al. 2017) | | |
|
| 293 | +| TIPARP | 2 | (Reddy et al. 2017) | | |
|
| 294 | +| TLR2 | 2 | (Chapuy et al. 2018) | | |
|
| 295 | +| TMEM30A | 1 | (Morin et al. 2011) | | |
|
| 296 | +| TMSB4X | 1 | (Albuquerque et al. 2017) | | |
|
| 297 | +| TNFAIP3 | 1 | (Compagno et al. 2009) | | |
|
| 298 | +| TNFRSF14 | 1 | (Cheung et al. 2010) | | |
|
| 299 | +| TOX | 1 | (Reddy et al. 2017) | | |
|
| 300 | +| TP53 | 1 | | (Morin et al. 2011) | |
|
| 301 | +| TRAF3 | 2 | (Laura Pasqualucci, Trifonov, et al. 2011) | | |
|
| 302 | +| TRAF6 | 2 | (Hübschmann et al. 2021) | | |
|
| 303 | +| TRIP12 | 1 | | | |
|
| 304 | +| TRRAP | 1 | (Parry et al. 2013) | | |
|
| 305 | +| UBE2A | 1 | (Reddy et al. 2017) | | |
|
| 306 | +| UBE2J1 | 2 | | | |
|
| 307 | +| UBR5 | 2 | (Zhang et al. 2013) | | |
|
| 308 | +| UNC5B | 2 | (Hübschmann et al. 2021) | | |
|
| 309 | +| UNC5C | 1 | | | |
|
| 310 | +| UNC5D | 2 | | | |
|
| 311 | +| USP7 | 1 | | | |
|
| 312 | +| VPS13B | 1 | | | |
|
| 313 | +| WAC | 2 | (Reddy et al. 2017) | | |
|
| 314 | +| WDFY3 | 2 | (Morin et al. 2013) | | |
|
| 315 | +| WEE1 | 1 | (Schmitz et al. 2018) | | |
|
| 316 | +| WNK1 | 2 | (Hübschmann et al. 2021) | | |
|
| 317 | +| XBP1 | 2 | | | |
|
| 318 | +| XPO1 | 1 | (Mareschal et al. 2016) | | |
|
| 319 | +| YY1 | 2 | (Reddy et al. 2017) | | |
|
| 320 | +| ZBTB7A | 2 | (Reddy et al. 2017) | | |
|
| 321 | +| ZC3H12A | 1 | (Arthur et al. 2018) | | |
|
| 322 | +| ZCCHC7 | 2 | (Arthur et al. 2018) | | |
|
| 323 | +| ZEB2 | 2 | (Zhang et al. 2013) | | |
|
| 324 | +| ZFAT | 2 | (Reddy et al. 2017) | | |
|
| 325 | +| ZFP36L1 | 1 | (Morin et al. 2011) | | |
|
| 326 | +| ZFX | 2 | (Reddy et al. 2017) | | |
|
| 327 | +| ZNF217 | 2 | (Hübschmann et al. 2021) | | |
|
| 328 | +| ZNF292 | 1 | (Zhang et al. 2013) | | |
|
| 329 | +| ZNF423 | 2 | (Chapuy et al. 2018) | | |
|
| 330 | +| ZNF608 | 1 | (Zhang et al. 2013) | (Krysiak et al. 2017) | |
|
| 331 | + |
|
| 332 | +# References |
|
| 333 | + |
|
| 334 | +<div id="refs" class="references csl-bib-body hanging-indent"> |
|
| 335 | + |
|
| 336 | +<div id="ref-albuquerqueEnhancingKnowledgeDiscovery2017a" |
|
| 337 | +class="csl-entry"> |
|
| 338 | + |
|
| 339 | +Albuquerque, Marco A., Bruno M. Grande, Elie J. Ritch, Prasath |
|
| 340 | +Pararajalingam, Selin Jessa, Martin Krzywinski, Jasleen K. Grewal, |
|
| 341 | +Sohrab P. Shah, Paul C. Boutros, and Ryan D. Morin. 2017. “Enhancing |
|
| 342 | +Knowledge Discovery from Cancer Genomics Data with Galaxy.” |
|
| 343 | +*GigaScience* 6 (5): 1–13. <https://doi.org/10.1093/gigascience/gix015>. |
|
| 344 | + |
|
| 345 | +</div> |
|
| 346 | + |
|
| 347 | +<div id="ref-arthurGenomewideDiscoverySomatic2018" class="csl-entry"> |
|
| 348 | + |
|
| 349 | +Arthur, Sarah E., Aixiang Jiang, Bruno M. Grande, Miguel Alcaide, Razvan |
|
| 350 | +Cojocaru, Christopher K. Rushton, Anja Mottok, et al. 2018. “Genome-Wide |
|
| 351 | +Discovery of Somatic Regulatory Variants in Diffuse Large <span |
|
| 352 | +class="nocase">B-cell</span> Lymphoma.” *Nature Communications* 9 (1): |
|
| 353 | +4001. <https://doi.org/10.1038/s41467-018-06354-3>. |
|
| 354 | + |
|
| 355 | +</div> |
|
| 356 | + |
|
| 357 | +<div id="ref-bohleRoleEarlyBcell2013" class="csl-entry"> |
|
| 358 | + |
|
| 359 | +Bohle, V., C. Döring, M.-L. Hansmann, and R. Küppers. 2013. “Role of |
|
| 360 | +Early <span class="nocase">B-cell</span> Factor 1 (EBF1) in Hodgkin |
|
| 361 | +Lymphoma.” *Leukemia* 27 (3): 671–79. |
|
| 362 | +<https://doi.org/10.1038/leu.2012.280>. |
|
| 363 | + |
|
| 364 | +</div> |
|
| 365 | + |
|
| 366 | +<div id="ref-chapuyMolecularSubtypesDiffuse2018b" class="csl-entry"> |
|
| 367 | + |
|
| 368 | +Chapuy, Bjoern, Chip Stewart, Andrew J. Dunford, Jaegil Kim, Atanas |
|
| 369 | +Kamburov, Robert A. Redd, Mike S. Lawrence, et al. 2018. “Molecular |
|
| 370 | +Subtypes of Diffuse Large B Cell Lymphoma Are Associated with Distinct |
|
| 371 | +Pathogenic Mechanisms and Outcomes.” *Nature Medicine* 24 (5): 679–90. |
|
| 372 | +<https://doi.org/10.1038/s41591-018-0016-8>. |
|
| 373 | + |
|
| 374 | +</div> |
|
| 375 | + |
|
| 376 | +<div id="ref-cheungAcquiredTNFRSF14Mutations2010a" class="csl-entry"> |
|
| 377 | + |
|
| 378 | +Cheung, K.-John J., Nathalie A. Johnson, Joslynn G. Affleck, Tesa |
|
| 379 | +Severson, Christian Steidl, Susana Ben-Neriah, Jacqueline Schein, et al. |
|
| 380 | +2010. “Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated |
|
| 381 | +with Worse Prognosis.” *Cancer Research* 70 (22): 9166–74. |
|
| 382 | +<https://doi.org/10.1158/0008-5472.CAN-10-2460>. |
|
| 383 | + |
|
| 384 | +</div> |
|
| 385 | + |
|
| 386 | +<div id="ref-compagnoMutationsMultipleGenes2009a" class="csl-entry"> |
|
| 387 | + |
|
| 388 | +Compagno, Mara, Wei Keat Lim, Adina Grunn, Subhadra V. Nandula, Manisha |
|
| 389 | +Brahmachary, Qiong Shen, Francesco Bertoni, et al. 2009. “Mutations of |
|
| 390 | +Multiple Genes Cause Deregulation of <span |
|
| 391 | +class="nocase">NF-kappaB</span> in Diffuse Large <span |
|
| 392 | +class="nocase">B-cell</span> Lymphoma.” *Nature* 459 (7247): 717–21. |
|
| 393 | +<https://doi.org/10.1038/nature07968>. |
|
| 394 | + |
|
| 395 | +</div> |
|
| 396 | + |
|
| 397 | +<div id="ref-dunsCharacterizationDLBCLPMBL2021b" class="csl-entry"> |
|
| 398 | + |
|
| 399 | +Duns, Gerben, Elena Viganò, Daisuke Ennishi, Clementine Sarkozy, Stacy |
|
| 400 | +S. Hung, Elizabeth Chavez, Katsuyoshi Takata, et al. 2021. |
|
| 401 | +“Characterization of DLBCL with a PMBL Gene Expression Signature.” |
|
| 402 | +*Blood* 138 (2): 136–48. <https://doi.org/10.1182/blood.2020007683>. |
|
| 403 | + |
|
| 404 | +</div> |
|
| 405 | + |
|
| 406 | +<div id="ref-hubschmannMutationalMechanismsShaping2021b" |
|
| 407 | +class="csl-entry"> |
|
| 408 | + |
|
| 409 | +Hübschmann, Daniel, Kortine Kleinheinz, Rabea Wagener, Stephan H. |
|
| 410 | +Bernhart, Cristina López, Umut H. Toprak, Stephanie Sungalee, et al. |
|
| 411 | +2021. “Mutational Mechanisms Shaping the Coding and Noncoding Genome of |
|
| 412 | +Germinal Center Derived <span class="nocase">B-cell</span> Lymphomas.” |
|
| 413 | +*Leukemia* 35 (7): 2002–16. |
|
| 414 | +<https://doi.org/10.1038/s41375-021-01251-z>. |
|
| 415 | + |
|
| 416 | +</div> |
|
| 417 | + |
|
| 418 | +<div id="ref-khodabakhshiRecurrentTargetsAberrant2012" |
|
| 419 | +class="csl-entry"> |
|
| 420 | + |
|
| 421 | +Khodabakhshi, Alireza Hadj, Ryan D. Morin, Anthony P. Fejes, Andrew J. |
|
| 422 | +Mungall, Karen L. Mungall, Madison Bolger-Munro, Nathalie A. Johnson, et |
|
| 423 | +al. 2012. “Recurrent Targets of Aberrant Somatic Hypermutation in |
|
| 424 | +Lymphoma.” *Oncotarget* 3 (11): 1308–19. |
|
| 425 | +<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717795/>. |
|
| 426 | + |
|
| 427 | +</div> |
|
| 428 | + |
|
| 429 | +<div id="ref-krysiakRecurrentSomaticMutations2017b" class="csl-entry"> |
|
| 430 | + |
|
| 431 | +Krysiak, Kilannin, Felicia Gomez, Brian S. White, Matthew Matlock, |
|
| 432 | +Christopher A. Miller, Lee Trani, Catrina C. Fronick, et al. 2017. |
|
| 433 | +“Recurrent Somatic Mutations Affecting <span |
|
| 434 | +class="nocase">B-cell</span> Receptor Signaling Pathway Genes in |
|
| 435 | +Follicular Lymphoma.” *Blood* 129 (4): 473–83. |
|
| 436 | +<https://doi.org/10.1182/blood-2016-07-729954>. |
|
| 437 | + |
|
| 438 | +</div> |
|
| 439 | + |
|
| 440 | +<div id="ref-kwanhianMicroRNA142Mutated202012b" class="csl-entry"> |
|
| 441 | + |
|
| 442 | +Kwanhian, Wiyada, Dido Lenze, Julia Alles, Natalie Motsch, Stephanie |
|
| 443 | +Barth, Celina Döll, Jochen Imig, et al. 2012. “MicroRNA-142 Is Mutated |
|
| 444 | +in about 20% of Diffuse Large <span class="nocase">B-cell</span> |
|
| 445 | +Lymphoma.” *Cancer Medicine* 1 (2): 141–55. |
|
| 446 | +<https://doi.org/10.1002/cam4.29>. |
|
| 447 | + |
|
| 448 | +</div> |
|
| 449 | + |
|
| 450 | +<div id="ref-lakeMutationsNFKBIAEncoding2009" class="csl-entry"> |
|
| 451 | + |
|
| 452 | +Lake, Annette, Lesley A. Shield, Pablo Cordano, Daniel T. Y. Chui, Julie |
|
| 453 | +Osborne, Shauna Crae, Katherine S. Wilson, et al. 2009. “Mutations of |
|
| 454 | +NFKBIA, Encoding IkappaB Alpha, Are a Recurrent Finding in Classical |
|
| 455 | +Hodgkin Lymphoma but Are Not a Unifying Feature of Non-<span |
|
| 456 | +class="nocase">EBV-associated</span> Cases.” *International Journal of |
|
| 457 | +Cancer* 125 (6): 1334–42. <https://doi.org/10.1002/ijc.24502>. |
|
| 458 | + |
|
| 459 | +</div> |
|
| 460 | + |
|
| 461 | +<div id="ref-lenzOncogenicCARD11Mutations2008" class="csl-entry"> |
|
| 462 | + |
|
| 463 | +Lenz, Georg, R Eric Davis, Vu N Ngo, Lloyd Lam, Thaddeus C George, |
|
| 464 | +George W Wright, Sandeep S Dave, et al. 2008. “Oncogenic CARD11 |
|
| 465 | +Mutations in Human Diffuse Large B Cell Lymphoma.” *Science* 319 (5870): |
|
| 466 | +1676–79. |
|
| 467 | + |
|
| 468 | +</div> |
|
| 469 | + |
|
| 470 | +<div id="ref-lohrDiscoveryPrioritizationSomatic2012a" class="csl-entry"> |
|
| 471 | + |
|
| 472 | +Lohr, Jens G., Petar Stojanov, Michael S. Lawrence, Daniel Auclair, |
|
| 473 | +Bjoern Chapuy, Carrie Sougnez, Peter Cruz-Gordillo, et al. 2012. |
|
| 474 | +“Discovery and Prioritization of Somatic Mutations in Diffuse Large |
|
| 475 | +<span class="nocase">B-cell</span> Lymphoma (DLBCL) by Whole-Exome |
|
| 476 | +Sequencing.” *Proceedings of the National Academy of Sciences of the |
|
| 477 | +United States of America* 109 (10): 3879–84. |
|
| 478 | +<https://doi.org/10.1073/pnas.1121343109>. |
|
| 479 | + |
|
| 480 | +</div> |
|
| 481 | + |
|
| 482 | +<div id="ref-louissaintPediatrictypeNodalFollicular2016a" |
|
| 483 | +class="csl-entry"> |
|
| 484 | + |
|
| 485 | +Louissaint, Abner, Kristian T. Schafernak, Julia T. Geyer, Alexandra E. |
|
| 486 | +Kovach, Mahmoud Ghandi, Dita Gratzinger, Christine G. Roth, et al. 2016. |
|
| 487 | +“Pediatric-Type Nodal Follicular Lymphoma: A Biologically Distinct |
|
| 488 | +Lymphoma with Frequent MAPK Pathway Mutations.” *Blood* 128 (8): |
|
| 489 | +1093–1100. <https://doi.org/10.1182/blood-2015-12-682591>. |
|
| 490 | + |
|
| 491 | +</div> |
|
| 492 | + |
|
| 493 | +<div id="ref-mareschalWholeExomeSequencing2016" class="csl-entry"> |
|
| 494 | + |
|
| 495 | +Mareschal, Sylvain, Sydney Dubois, Pierre-Julien Viailly, Philippe |
|
| 496 | +Bertrand, Elodie Bohers, Catherine Maingonnat, Jean-Philippe Jaïs, et |
|
| 497 | +al. 2016. “Whole Exome Sequencing of Relapsed/Refractory Patients |
|
| 498 | +Expands the Repertoire of Somatic Mutations in Diffuse Large <span |
|
| 499 | +class="nocase">B-cell</span> Lymphoma.” *Genes, Chromosomes & Cancer* 55 |
|
| 500 | +(3): 251–67. <https://doi.org/10.1002/gcc.22328>. |
|
| 501 | + |
|
| 502 | +</div> |
|
| 503 | + |
|
| 504 | +<div id="ref-morinGeneticLandscapesRelapsed2016" class="csl-entry"> |
|
| 505 | + |
|
| 506 | +Morin, Ryan D., Sarit Assouline, Miguel Alcaide, Arezoo Mohajeri, |
|
| 507 | +Rebecca L. Johnston, Lauren Chong, Jasleen Grewal, et al. 2016. “Genetic |
|
| 508 | +Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.” |
|
| 509 | +*Clinical Cancer Research: An Official Journal of the American |
|
| 510 | +Association for Cancer Research* 22 (9): 2290–300. |
|
| 511 | +<https://doi.org/10.1158/1078-0432.CCR-15-2123>. |
|
| 512 | + |
|
| 513 | +</div> |
|
| 514 | + |
|
| 515 | +<div id="ref-morinSomaticMutationsAltering2010a" class="csl-entry"> |
|
| 516 | + |
|
| 517 | +Morin, Ryan D., Nathalie A. Johnson, Tesa M. Severson, Andrew J. |
|
| 518 | +Mungall, Jianghong An, Rodrigo Goya, Jessica E. Paul, et al. 2010. |
|
| 519 | +“Somatic Mutations Altering EZH2 (Tyr641) in Follicular and Diffuse |
|
| 520 | +Large <span class="nocase">B-cell</span> Lymphomas of Germinal-Center |
|
| 521 | +Origin.” *Nature Genetics* 42 (2): 181–85. |
|
| 522 | +<https://doi.org/10.1038/ng.518>. |
|
| 523 | + |
|
| 524 | +</div> |
|
| 525 | + |
|
| 526 | +<div id="ref-morinFrequentMutationHistonemodifying2011" |
|
| 527 | +class="csl-entry"> |
|
| 528 | + |
|
| 529 | +Morin, Ryan D., Maria Mendez-Lago, Andrew J. Mungall, Rodrigo Goya, |
|
| 530 | +Karen L. Mungall, Richard D. Corbett, Nathalie A. Johnson, et al. 2011. |
|
| 531 | +“Frequent Mutation of Histone-Modifying Genes in Non-Hodgkin Lymphoma.” |
|
| 532 | +*Nature* 476 (7360): 298–303. <https://doi.org/10.1038/nature10351>. |
|
| 533 | + |
|
| 534 | +</div> |
|
| 535 | + |
|
| 536 | +<div id="ref-morinMutationalStructuralAnalysis2013" class="csl-entry"> |
|
| 537 | + |
|
| 538 | +Morin, Ryan D., Karen Mungall, Erin Pleasance, Andrew J. Mungall, |
|
| 539 | +Rodrigo Goya, Ryan D. Huff, David W. Scott, et al. 2013. “Mutational and |
|
| 540 | +Structural Analysis of Diffuse Large <span class="nocase">B-cell</span> |
|
| 541 | +Lymphoma Using Whole-Genome Sequencing.” *Blood* 122 (7): 1256–65. |
|
| 542 | +<https://doi.org/10.1182/blood-2013-02-483727>. |
|
| 543 | + |
|
| 544 | +</div> |
|
| 545 | + |
|
| 546 | +<div id="ref-ngoOncogenicallyActiveMYD882011a" class="csl-entry"> |
|
| 547 | + |
|
| 548 | +Ngo, Vu N., Ryan M. Young, Roland Schmitz, Sameer Jhavar, Wenming Xiao, |
|
| 549 | +Kian-Huat Lim, Holger Kohlhammer, et al. 2011. “Oncogenically Active |
|
| 550 | +MYD88 Mutations in Human Lymphoma.” *Nature* 470 (7332): 115–19. |
|
| 551 | +<https://doi.org/10.1038/nature09671>. |
|
| 552 | + |
|
| 553 | +</div> |
|
| 554 | + |
|
| 555 | +<div id="ref-ohgamiSTAT3MutationsAre2014" class="csl-entry"> |
|
| 556 | + |
|
| 557 | +Ohgami, Robert S., Lisa Ma, Ahmad Monabati, James L. Zehnder, and Daniel |
|
| 558 | +A. Arber. 2014. “STAT3 Mutations Are Present in Aggressive <span |
|
| 559 | +class="nocase">B-cell</span> Lymphomas Including a Subset of Diffuse |
|
| 560 | +Large <span class="nocase">B-cell</span> Lymphomas with CD30 |
|
| 561 | +Expression.” *Haematologica* 99 (7): e105–107. |
|
| 562 | +<https://doi.org/10.3324/haematol.2013.101543>. |
|
| 563 | + |
|
| 564 | +</div> |
|
| 565 | + |
|
| 566 | +<div id="ref-okosunRecurrentMTORC1activatingRRAGC2016a" |
|
| 567 | +class="csl-entry"> |
|
| 568 | + |
|
| 569 | +Okosun, Jessica, Rachel L. Wolfson, Jun Wang, Shamzah Araf, Lucy |
|
| 570 | +Wilkins, Brian M. Castellano, Leire Escudero-Ibarz, et al. 2016. |
|
| 571 | +“Recurrent <span class="nocase">mTORC1-activating RRAGC</span> Mutations |
|
| 572 | +in Follicular Lymphoma.” *Nature Genetics* 48 (2): 183–88. |
|
| 573 | +<https://doi.org/10.1038/ng.3473>. |
|
| 574 | + |
|
| 575 | +</div> |
|
| 576 | + |
|
| 577 | +<div id="ref-pararajalingamCodingNoncodingDrivers2020" |
|
| 578 | +class="csl-entry"> |
|
| 579 | + |
|
| 580 | +Pararajalingam, Prasath, Krysta M. Coyle, Sarah E. Arthur, Nicole |
|
| 581 | +Thomas, Miguel Alcaide, Barbara Meissner, Merrill Boyle, et al. 2020. |
|
| 582 | +“Coding and Noncoding Drivers of Mantle Cell Lymphoma Identified Through |
|
| 583 | +Exome and Genome Sequencing.” *Blood* 136 (5): 572–84. |
|
| 584 | +<https://doi.org/10.1182/blood.2019002385>. |
|
| 585 | + |
|
| 586 | +</div> |
|
| 587 | + |
|
| 588 | +<div id="ref-parryWholeExomeSequencing2013" class="csl-entry"> |
|
| 589 | + |
|
| 590 | +Parry, Marina, Matthew J. J. Rose-Zerilli, Jane Gibson, Sarah Ennis, |
|
| 591 | +Renata Walewska, Jade Forster, Helen Parker, et al. 2013. “Whole Exome |
|
| 592 | +Sequencing Identifies Novel Recurrently Mutated Genes in Patients with |
|
| 593 | +Splenic Marginal Zone Lymphoma.” *PloS One* 8 (12): e83244. |
|
| 594 | +<https://doi.org/10.1371/journal.pone.0083244>. |
|
| 595 | + |
|
| 596 | +</div> |
|
| 597 | + |
|
| 598 | +<div id="ref-pasqualucciInactivatingMutationsAcetyltransferase2011a" |
|
| 599 | +class="csl-entry"> |
|
| 600 | + |
|
| 601 | +Pasqualucci, Laura, David Dominguez-Sola, Annalisa Chiarenza, Giulia |
|
| 602 | +Fabbri, Adina Grunn, Vladimir Trifonov, Lawryn H. Kasper, et al. 2011. |
|
| 603 | +“Inactivating Mutations of Acetyltransferase Genes in <span |
|
| 604 | +class="nocase">B-cell</span> Lymphoma.” *Nature* 471 (7337): 189–95. |
|
| 605 | +<https://doi.org/10.1038/nature09730>. |
|
| 606 | + |
|
| 607 | +</div> |
|
| 608 | + |
|
| 609 | +<div id="ref-pasqualucciAnalysisCodingGenome2011" class="csl-entry"> |
|
| 610 | + |
|
| 611 | +Pasqualucci, Laura, Vladimir Trifonov, Giulia Fabbri, Jing Ma, Davide |
|
| 612 | +Rossi, Annalisa Chiarenza, Victoria A. Wells, et al. 2011. “Analysis of |
|
| 613 | +the Coding Genome of Diffuse Large <span class="nocase">B-cell</span> |
|
| 614 | +Lymphoma.” *Nature Genetics* 43 (9): 830–37. |
|
| 615 | +<https://doi.org/10.1038/ng.892>. |
|
| 616 | + |
|
| 617 | +</div> |
|
| 618 | + |
|
| 619 | +<div id="ref-pasqualucciHypermutationMultipleProtooncogenes2001a" |
|
| 620 | +class="csl-entry"> |
|
| 621 | + |
|
| 622 | +Pasqualucci, L., P. Neumeister, T. Goossens, G. Nanjangud, R. S. |
|
| 623 | +Chaganti, R. Küppers, and R. Dalla-Favera. 2001. “Hypermutation of |
|
| 624 | +Multiple Proto-Oncogenes in <span class="nocase">B-cell</span> Diffuse |
|
| 625 | +Large-Cell Lymphomas.” *Nature* 412 (6844): 341–46. |
|
| 626 | +<https://doi.org/10.1038/35085588>. |
|
| 627 | + |
|
| 628 | +</div> |
|
| 629 | + |
|
| 630 | +<div id="ref-reddyGeneticFunctionalDrivers2017" class="csl-entry"> |
|
| 631 | + |
|
| 632 | +Reddy, Anupama, Jenny Zhang, Nicholas S Davis, Andrea B Moffitt, |
|
| 633 | +Cassandra L Love, Alexander Waldrop, Sirpa Leppa, et al. 2017. “Genetic |
|
| 634 | +and Functional Drivers of Diffuse Large B Cell Lymphoma.” *Cell* 171 |
|
| 635 | +(2): 481–494.e15. |
|
| 636 | + |
|
| 637 | +</div> |
|
| 638 | + |
|
| 639 | +<div id="ref-rossiCodingGenomeSplenic2012c" class="csl-entry"> |
|
| 640 | + |
|
| 641 | +Rossi, Davide, Vladimir Trifonov, Marco Fangazio, Alessio Bruscaggin, |
|
| 642 | +Silvia Rasi, Valeria Spina, Sara Monti, et al. 2012. “The Coding Genome |
|
| 643 | +of Splenic Marginal Zone Lymphoma: Activation of NOTCH2 and Other |
|
| 644 | +Pathways Regulating Marginal Zone Development.” *The Journal of |
|
| 645 | +Experimental Medicine* 209 (9): 1537–51. |
|
| 646 | +<https://doi.org/10.1084/jem.20120904>. |
|
| 647 | + |
|
| 648 | +</div> |
|
| 649 | + |
|
| 650 | +<div id="ref-rushtonGeneticEvolutionaryPatterns2020" class="csl-entry"> |
|
| 651 | + |
|
| 652 | +Rushton, Christopher K., Sarah E. Arthur, Miguel Alcaide, Matthew |
|
| 653 | +Cheung, Aixiang Jiang, Krysta M. Coyle, Kirstie L. S. Cleary, et al. |
|
| 654 | +2020. “Genetic and Evolutionary Patterns of Treatment Resistance in |
|
| 655 | +Relapsed <span class="nocase">B-cell</span> Lymphoma.” *Blood Advances* |
|
| 656 | +4 (13): 2886–98. <https://doi.org/10.1182/bloodadvances.2020001696>. |
|
| 657 | + |
|
| 658 | +</div> |
|
| 659 | + |
|
| 660 | +<div id="ref-russler-germainMutationsAssociatedProgression2023b" |
|
| 661 | +class="csl-entry"> |
|
| 662 | + |
|
| 663 | +Russler-Germain, David A., Kilannin Krysiak, Cody A. Ramirez, Matthew |
|
| 664 | +Mosior, Marcus P. Watkins, Felicia Gomez, Zachary L. Skidmore, et al. |
|
| 665 | +2023. “Mutations Associated with Progression in Follicular Lymphoma |
|
| 666 | +Predict Inferior Outcomes at Diagnosis: Alliance A151303.” *Blood |
|
| 667 | +Advances* 7: 5524–39. |
|
| 668 | +<https://doi.org/10.1182/bloodadvances.2023010779>. |
|
| 669 | + |
|
| 670 | +</div> |
|
| 671 | + |
|
| 672 | +<div id="ref-schmitzGeneticsPathogenesisDiffuse2018a" class="csl-entry"> |
|
| 673 | + |
|
| 674 | +Schmitz, Roland, George W. Wright, Da Wei Huang, Calvin A. Johnson, |
|
| 675 | +James D. Phelan, James Q. Wang, Sandrine Roulland, et al. 2018. |
|
| 676 | +“Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.” *The New |
|
| 677 | +England Journal of Medicine* 378 (15): 1396–1407. |
|
| 678 | +<https://doi.org/10.1056/NEJMoa1801445>. |
|
| 679 | + |
|
| 680 | +</div> |
|
| 681 | + |
|
| 682 | +<div id="ref-schmitzBurkittLymphomaPathogenesis2012" class="csl-entry"> |
|
| 683 | + |
|
| 684 | +Schmitz, Roland, Ryan M. Young, Michele Ceribelli, Sameer Jhavar, |
|
| 685 | +Wenming Xiao, Meili Zhang, George Wright, et al. 2012. “Burkitt Lymphoma |
|
| 686 | +Pathogenesis and Therapeutic Targets from Structural and Functional |
|
| 687 | +Genomics.” *Nature* 490 (7418): 116–20. |
|
| 688 | +<https://doi.org/10.1038/nature11378>. |
|
| 689 | + |
|
| 690 | +</div> |
|
| 691 | + |
|
| 692 | +<div id="ref-schollMutationsRegionFAS2007" class="csl-entry"> |
|
| 693 | + |
|
| 694 | +Scholl, Vanesa, Claudio Gustavo Stefanoff, Rocio Hassan, Nelson Spector, |
|
| 695 | +and Ilana Zalcberg Renault. 2007. “Mutations Within the 5’ Region of |
|
| 696 | +FAS/CD95 Gene in Nodal Diffuse Large <span class="nocase">B-cell</span> |
|
| 697 | +Lymphoma.” *Leukemia & Lymphoma* 48 (5): 957–63. |
|
| 698 | +<https://doi.org/10.1080/10428190701230858>. |
|
| 699 | + |
|
| 700 | +</div> |
|
| 701 | + |
|
| 702 | +<div id="ref-shinBRAFV600EMAP2K12015" class="csl-entry"> |
|
| 703 | + |
|
| 704 | +Shin, Sang-Yong, Seung-Tae Lee, Hee-Jin Kim, Chang-Seok Ki, Chul Won |
|
| 705 | +Jung, Jong-Won Kim, and Sun-Hee Kim. 2015. “BRAF V600E and MAP2K1 |
|
| 706 | +Mutations in Hairy Cell Leukemia and Splenic Marginal Zone Lymphoma |
|
| 707 | +Cases.” *Annals of Laboratory Medicine* 35 (2): 257–59. |
|
| 708 | +<https://doi.org/10.3343/alm.2015.35.2.257>. |
|
| 709 | + |
|
| 710 | +</div> |
|
| 711 | + |
|
| 712 | +<div id="ref-tanakaFrequentIncidenceSomatic1992" class="csl-entry"> |
|
| 713 | + |
|
| 714 | +Tanaka, S., D. C. Louie, J. A. Kant, and J. C. Reed. 1992. “Frequent |
|
| 715 | +Incidence of Somatic Mutations in Translocated BCL2 Oncogenes of |
|
| 716 | +Non-Hodgkin’s Lymphomas.” *Blood* 79 (1): 229–37. |
|
| 717 | + |
|
| 718 | +</div> |
|
| 719 | + |
|
| 720 | +<div id="ref-tiacciBRAFMutationsHairycell2011a" class="csl-entry"> |
|
| 721 | + |
|
| 722 | +Tiacci, Enrico, Vladimir Trifonov, Gianluca Schiavoni, Antony Holmes, |
|
| 723 | +Wolfgang Kern, Maria Paola Martelli, Alessandra Pucciarini, et al. 2011. |
|
| 724 | +“BRAF Mutations in Hairy-Cell Leukemia.” *The New England Journal of |
|
| 725 | +Medicine* 364 (24): 2305–15. <https://doi.org/10.1056/NEJMoa1014209>. |
|
| 726 | + |
|
| 727 | +</div> |
|
| 728 | + |
|
| 729 | +<div id="ref-troenNOTCH2MutationsMarginal2008" class="csl-entry"> |
|
| 730 | + |
|
| 731 | +Trøen, Gunhild, Iwona Wlodarska, Abdirashid Warsame, Silvia Hernández |
|
| 732 | +Llodrà, Christiane De Wolf-Peeters, and Jan Delabie. 2008. “NOTCH2 |
|
| 733 | +Mutations in Marginal Zone Lymphoma.” *Haematologica* 93 (7): 1107–9. |
|
| 734 | +<https://doi.org/10.3324/haematol.11635>. |
|
| 735 | + |
|
| 736 | +</div> |
|
| 737 | + |
|
| 738 | +<div id="ref-yildizActivatingSTAT6Mutations2015c" class="csl-entry"> |
|
| 739 | + |
|
| 740 | +Yildiz, Mehmet, Hongxiu Li, Denzil Bernard, Nisar A. Amin, Peter |
|
| 741 | +Ouillette, Siân Jones, Kamlai Saiya-Cork, et al. 2015. “Activating STAT6 |
|
| 742 | +Mutations in Follicular Lymphoma.” *Blood* 125 (4): 668–79. |
|
| 743 | +<https://doi.org/10.1182/blood-2014-06-582650>. |
|
| 744 | + |
|
| 745 | +</div> |
|
| 746 | + |
|
| 747 | +<div id="ref-zhangGeneticHeterogeneityDiffuse2013" class="csl-entry"> |
|
| 748 | + |
|
| 749 | +Zhang, Jenny, Vladimir Grubor, Cassandra L Love, Anjishnu Banerjee, |
|
| 750 | +Kristy L Richards, Piotr A Mieczkowski, Cherie Dunphy, et al. 2013. |
|
| 751 | +“Genetic Heterogeneity of Diffuse Large <span |
|
| 752 | +class="nocase">B-cell</span> Lymphoma.” January. |
|
| 753 | + |
|
| 754 | +</div> |
|
| 755 | + |
|
| 756 | +</div> |
FL_genes_with_bib.md
| ... | ... | @@ -0,0 +1,457 @@ |
| 1 | +# FL genes |
|
| 2 | + |
|
| 3 | +| Gene | Tier | FL Reference | Other references | |
|
| 4 | +|:---------:|:----:|:------------------------------------------------:|:------------------------------------------:| |
|
| 5 | +| ABL2 | 2 | (Russler-Germain et al. 2023) | | |
|
| 6 | +| ACTB | 1 | | (Lohr et al. 2012) | |
|
| 7 | +| ACTG1 | 2 | (Hübschmann et al. 2021) | | |
|
| 8 | +| ARID1A | 1 | (Krysiak et al. 2017) | (Zhang et al. 2013) | |
|
| 9 | +| ATP6AP1 | 1 | (Okosun et al. 2016) | | |
|
| 10 | +| ATP6V1A | 2 | (Hübschmann et al. 2021) | | |
|
| 11 | +| ATP6V1B2 | 1 | (Okosun et al. 2016) | | |
|
| 12 | +| B2M | 1 | (Morin et al. 2011) | | |
|
| 13 | +| BCL10 | 2 | (Russler-Germain et al. 2023) | (Morin et al. 2011) | |
|
| 14 | +| BCL2 | 1 | (Morin et al. 2011) | (Tanaka et al. 1992) | |
|
| 15 | +| BCL6 | 1 | | (Morin et al. 2011) | |
|
| 16 | +| BCL7A | 1 | (Krysiak et al. 2017) | (Arthur et al. 2018) | |
|
| 17 | +| BIRC6 | 1 | | (Reddy et al. 2017) | |
|
| 18 | +| BTG1 | 1 | | (Morin et al. 2011) | |
|
| 19 | +| BTG2 | 1 | (Morin et al. 2011) | | |
|
| 20 | +| BTK | 1 | (Krysiak et al. 2017) | (Albuquerque et al. 2017) | |
|
| 21 | +| CARD11 | 1 | (Morin et al. 2011) | (Lenz et al. 2008) | |
|
| 22 | +| CCDC42BPB | 2 | (Hübschmann et al. 2021) | | |
|
| 23 | +| CCND3 | 1 | (Morin et al. 2011) | | |
|
| 24 | +| CD70 | 2 | (Russler-Germain et al. 2023) | (Morin et al. 2011) | |
|
| 25 | +| CD79B | 2 | | (Morin et al. 2011) | |
|
| 26 | +| CD83 | 1 | (Russler-Germain et al. 2023) | (Morin et al. 2013) | |
|
| 27 | +| CILP | 2 | (Russler-Germain et al. 2023) | | |
|
| 28 | +| CPNE8 | 2 | (Hübschmann et al. 2021) | | |
|
| 29 | +| CREBBP | 1 | (Laura Pasqualucci, Dominguez-Sola, et al. 2011) | | |
|
| 30 | +| CTSS | 1 | (Bararia et al. 2020) | | |
|
| 31 | +| CXCR4 | 2 | (Krysiak et al. 2017) | (Khodabakhshi et al. 2012) | |
|
| 32 | +| CYP2A6 | 2 | (Russler-Germain et al. 2023) | | |
|
| 33 | +| DDX3X | 2 | | (Schmitz et al. 2018) | |
|
| 34 | +| DHX15 | 2 | (Hübschmann et al. 2021) | | |
|
| 35 | +| DTX1 | 1 | | (Schmitz et al. 2018) | |
|
| 36 | +| DUSP2 | 2 | | (Morin et al. 2013) | |
|
| 37 | +| EBF1 | 1 | | (Bohle et al. 2013) | |
|
| 38 | +| EEF1A1 | 1 | (Hübschmann et al. 2021) | | |
|
| 39 | +| EGR1 | 2 | (Krysiak et al. 2017) | | |
|
| 40 | +| EP300 | 1 | (Laura Pasqualucci, Dominguez-Sola, et al. 2011) | | |
|
| 41 | +| EZH2 | 1 | (Morin et al. 2010) | | |
|
| 42 | +| FAS | 1 | | (Scholl et al. 2007) | |
|
| 43 | +| FOXO1 | 1 | (Morin et al. 2011) | | |
|
| 44 | +| FZR1 | 2 | (Hübschmann et al. 2021) | | |
|
| 45 | +| GBP7 | 2 | (Russler-Germain et al. 2023) | | |
|
| 46 | +| GNA13 | 1 | (Morin et al. 2011) | | |
|
| 47 | +| GNAI2 | 1 | | (Morin et al. 2013) | |
|
| 48 | +| GRM6 | 2 | (Russler-Germain et al. 2023) | | |
|
| 49 | +| HIST1H1B | 1 | (Krysiak et al. 2017) | (Chapuy et al. 2018) | |
|
| 50 | +| HIST1H1C | 1 | (Morin et al. 2011) | | |
|
| 51 | +| HIST1H1D | 1 | (Krysiak et al. 2017) | (Morin et al. 2013) | |
|
| 52 | +| HIST1H1E | 1 | (Krysiak et al. 2017) | (Morin et al. 2013) | |
|
| 53 | +| HIST1H2AC | 1 | (Krysiak et al. 2017) | (Morin et al. 2013) | |
|
| 54 | +| HIST1H2AG | 1 | (Krysiak et al. 2017) | (Morin et al. 2013) | |
|
| 55 | +| HIST1H2AM | 1 | (Krysiak et al. 2017) | | |
|
| 56 | +| HIST1H2BC | 1 | (Krysiak et al. 2017) | (Reddy et al. 2017) | |
|
| 57 | +| HIST1H2BD | 1 | (Krysiak et al. 2017) | | |
|
| 58 | +| HIST1H2BG | 1 | (Krysiak et al. 2017) | | |
|
| 59 | +| HIST1H2BM | 2 | (Krysiak et al. 2017) | | |
|
| 60 | +| HIST1H3B | 1 | | (Zhang et al. 2013) | |
|
| 61 | +| HIST1H3G | 1 | (Krysiak et al. 2017) | | |
|
| 62 | +| HIST1H3I | 2 | (Krysiak et al. 2017) | | |
|
| 63 | +| HLA-B | 2 | | | |
|
| 64 | +| HNRNPD | 2 | | | |
|
| 65 | +| HVCN1 | 1 | (Krysiak et al. 2017) | | |
|
| 66 | +| IGLL5 | 2 | (Russler-Germain et al. 2023) | | |
|
| 67 | +| IRF4 | 1 | | (Morin et al. 2011) | |
|
| 68 | +| IRF8 | 1 | (Morin et al. 2011) | | |
|
| 69 | +| ITPKB | 1 | | (Schmitz et al. 2018) | |
|
| 70 | +| JUP | 2 | (Hübschmann et al. 2021) | | |
|
| 71 | +| KIR3DL1 | 2 | (Russler-Germain et al. 2023) | | |
|
| 72 | +| KLF2 | 1 | | (Laura Pasqualucci, Trifonov, et al. 2011) | |
|
| 73 | +| KLHL6 | 1 | (Morin et al. 2011) | | |
|
| 74 | +| KMT2D | 1 | (Morin et al. 2011) | | |
|
| 75 | +| LAPTM5 | 2 | (Hübschmann et al. 2021) | | |
|
| 76 | +| LTB | 1 | | (Chapuy et al. 2018) | |
|
| 77 | +| MAGEC1 | 2 | (Russler-Germain et al. 2023) | | |
|
| 78 | +| MAP2K1 | 1 | (Louissaint et al. 2016) | (Shin et al. 2015) | |
|
| 79 | +| MAP7D1 | 2 | (Russler-Germain et al. 2023) | | |
|
| 80 | +| MEF2B | 1 | (Morin et al. 2011) | | |
|
| 81 | +| MEF2C | 1 | | (Arthur et al. 2018) | |
|
| 82 | +| MGEA5 | 2 | (Hübschmann et al. 2021) | | |
|
| 83 | +| MKI67 | 2 | (Russler-Germain et al. 2023) | | |
|
| 84 | +| MYC | 2 | | (L. Pasqualucci et al. 2001) | |
|
| 85 | +| MYCBP2 | 2 | (Hübschmann et al. 2021) | | |
|
| 86 | +| MYD88 | 2 | | (Ngo et al. 2011) | |
|
| 87 | +| NFKBIA | 2 | (Russler-Germain et al. 2023) | (Lake et al. 2009) | |
|
| 88 | +| OR8H2 | 2 | (Russler-Germain et al. 2023) | | |
|
| 89 | +| P2RY8 | 2 | | (Lohr et al. 2012) | |
|
| 90 | +| PCLO | 1 | | (Lohr et al. 2012) | |
|
| 91 | +| PDS5B | 2 | (Hübschmann et al. 2021) | (Morin et al. 2013) | |
|
| 92 | +| PIM1 | 1 | | (L. Pasqualucci et al. 2001) | |
|
| 93 | +| POU2AF1 | 1 | (Krysiak et al. 2017) | | |
|
| 94 | +| POU2F2 | 1 | (Krysiak et al. 2017) | (Zhang et al. 2013) | |
|
| 95 | +| PPP4C | 2 | (Hübschmann et al. 2021) | | |
|
| 96 | +| PRKDC | 2 | (Hübschmann et al. 2021) | (Schmitz et al. 2018) | |
|
| 97 | +| PTPRD | 1 | | | |
|
| 98 | +| PZP | 2 | (Russler-Germain et al. 2023) | | |
|
| 99 | +| RBM6 | 2 | (Hübschmann et al. 2021) | | |
|
| 100 | +| RRAGC | 1 | | (Okosun et al. 2016) | |
|
| 101 | +| S1PR2 | 1 | | (Morin et al. 2011) | |
|
| 102 | +| SESN1 | 2 | (Oricchio et al. 2017) | | |
|
| 103 | +| SGK1 | 1 | (Morin et al. 2011) | | |
|
| 104 | +| SHROOM3 | 2 | (Russler-Germain et al. 2023) | | |
|
| 105 | +| SMARCA4 | 1 | (Krysiak et al. 2017) | (Zhang et al. 2013) | |
|
| 106 | +| SOCS1 | 1 | | (Morin et al. 2011) | |
|
| 107 | +| SRRM2 | 2 | (Russler-Germain et al. 2023) | (Morin et al. 2013) | |
|
| 108 | +| STAB2 | 2 | (Russler-Germain et al. 2023) | | |
|
| 109 | +| STAT6 | 1 | (Yildiz et al. 2015) | | |
|
| 110 | +| TBL1XR1 | 1 | | (Mareschal et al. 2016) | |
|
| 111 | +| TMEM30A | 2 | (Morin et al. 2011) | | |
|
| 112 | +| TMSB4X | 1 | | (Albuquerque et al. 2017) | |
|
| 113 | +| TNFAIP3 | 1 | | (Compagno et al. 2009) | |
|
| 114 | +| TNFRSF14 | 1 | (Cheung et al. 2010) | | |
|
| 115 | +| TP53 | 1 | (Morin et al. 2011) | | |
|
| 116 | +| TPP1 | 2 | (Hübschmann et al. 2021) | | |
|
| 117 | +| VMA21 | 1 | (Hübschmann et al. 2021) | | |
|
| 118 | +| XIRP2 | 2 | (Russler-Germain et al. 2023) | | |
|
| 119 | +| ZC3H12A | 2 | | (Arthur et al. 2018) | |
|
| 120 | +| ZNF608 | 2 | (Krysiak et al. 2017) | (Zhang et al. 2013) | |
|
| 121 | + |
|
| 122 | +# References |
|
| 123 | + |
|
| 124 | +<div id="refs" class="references csl-bib-body hanging-indent"> |
|
| 125 | + |
|
| 126 | +<div id="ref-albuquerqueEnhancingKnowledgeDiscovery2017a" |
|
| 127 | +class="csl-entry"> |
|
| 128 | + |
|
| 129 | +Albuquerque, Marco A., Bruno M. Grande, Elie J. Ritch, Prasath |
|
| 130 | +Pararajalingam, Selin Jessa, Martin Krzywinski, Jasleen K. Grewal, |
|
| 131 | +Sohrab P. Shah, Paul C. Boutros, and Ryan D. Morin. 2017. “Enhancing |
|
| 132 | +Knowledge Discovery from Cancer Genomics Data with Galaxy.” |
|
| 133 | +*GigaScience* 6 (5): 1–13. <https://doi.org/10.1093/gigascience/gix015>. |
|
| 134 | + |
|
| 135 | +</div> |
|
| 136 | + |
|
| 137 | +<div id="ref-arthurGenomewideDiscoverySomatic2018" class="csl-entry"> |
|
| 138 | + |
|
| 139 | +Arthur, Sarah E., Aixiang Jiang, Bruno M. Grande, Miguel Alcaide, Razvan |
|
| 140 | +Cojocaru, Christopher K. Rushton, Anja Mottok, et al. 2018. “Genome-Wide |
|
| 141 | +Discovery of Somatic Regulatory Variants in Diffuse Large <span |
|
| 142 | +class="nocase">B-cell</span> Lymphoma.” *Nature Communications* 9 (1): |
|
| 143 | +4001. <https://doi.org/10.1038/s41467-018-06354-3>. |
|
| 144 | + |
|
| 145 | +</div> |
|
| 146 | + |
|
| 147 | +<div id="ref-barariaCathepsinAlterationsInduce2020c" class="csl-entry"> |
|
| 148 | + |
|
| 149 | +Bararia, Deepak, Johannes A. Hildebrand, Sebastian Stolz, Sarah Haebe, |
|
| 150 | +Stefan Alig, Christopher P. Trevisani, Francisco Osorio-Barrios, et al. |
|
| 151 | +2020. “Cathepsin S Alterations Induce a Tumor-Promoting Immune |
|
| 152 | +Microenvironment in Follicular Lymphoma.” *Cell Reports* 31 (5): 107522. |
|
| 153 | +<https://doi.org/10.1016/j.celrep.2020.107522>. |
|
| 154 | + |
|
| 155 | +</div> |
|
| 156 | + |
|
| 157 | +<div id="ref-bohleRoleEarlyBcell2013" class="csl-entry"> |
|
| 158 | + |
|
| 159 | +Bohle, V., C. Döring, M.-L. Hansmann, and R. Küppers. 2013. “Role of |
|
| 160 | +Early <span class="nocase">B-cell</span> Factor 1 (EBF1) in Hodgkin |
|
| 161 | +Lymphoma.” *Leukemia* 27 (3): 671–79. |
|
| 162 | +<https://doi.org/10.1038/leu.2012.280>. |
|
| 163 | + |
|
| 164 | +</div> |
|
| 165 | + |
|
| 166 | +<div id="ref-chapuyMolecularSubtypesDiffuse2018b" class="csl-entry"> |
|
| 167 | + |
|
| 168 | +Chapuy, Bjoern, Chip Stewart, Andrew J. Dunford, Jaegil Kim, Atanas |
|
| 169 | +Kamburov, Robert A. Redd, Mike S. Lawrence, et al. 2018. “Molecular |
|
| 170 | +Subtypes of Diffuse Large B Cell Lymphoma Are Associated with Distinct |
|
| 171 | +Pathogenic Mechanisms and Outcomes.” *Nature Medicine* 24 (5): 679–90. |
|
| 172 | +<https://doi.org/10.1038/s41591-018-0016-8>. |
|
| 173 | + |
|
| 174 | +</div> |
|
| 175 | + |
|
| 176 | +<div id="ref-cheungAcquiredTNFRSF14Mutations2010a" class="csl-entry"> |
|
| 177 | + |
|
| 178 | +Cheung, K.-John J., Nathalie A. Johnson, Joslynn G. Affleck, Tesa |
|
| 179 | +Severson, Christian Steidl, Susana Ben-Neriah, Jacqueline Schein, et al. |
|
| 180 | +2010. “Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated |
|
| 181 | +with Worse Prognosis.” *Cancer Research* 70 (22): 9166–74. |
|
| 182 | +<https://doi.org/10.1158/0008-5472.CAN-10-2460>. |
|
| 183 | + |
|
| 184 | +</div> |
|
| 185 | + |
|
| 186 | +<div id="ref-compagnoMutationsMultipleGenes2009a" class="csl-entry"> |
|
| 187 | + |
|
| 188 | +Compagno, Mara, Wei Keat Lim, Adina Grunn, Subhadra V. Nandula, Manisha |
|
| 189 | +Brahmachary, Qiong Shen, Francesco Bertoni, et al. 2009. “Mutations of |
|
| 190 | +Multiple Genes Cause Deregulation of <span |
|
| 191 | +class="nocase">NF-kappaB</span> in Diffuse Large <span |
|
| 192 | +class="nocase">B-cell</span> Lymphoma.” *Nature* 459 (7247): 717–21. |
|
| 193 | +<https://doi.org/10.1038/nature07968>. |
|
| 194 | + |
|
| 195 | +</div> |
|
| 196 | + |
|
| 197 | +<div id="ref-hubschmannMutationalMechanismsShaping2021b" |
|
| 198 | +class="csl-entry"> |
|
| 199 | + |
|
| 200 | +Hübschmann, Daniel, Kortine Kleinheinz, Rabea Wagener, Stephan H. |
|
| 201 | +Bernhart, Cristina López, Umut H. Toprak, Stephanie Sungalee, et al. |
|
| 202 | +2021. “Mutational Mechanisms Shaping the Coding and Noncoding Genome of |
|
| 203 | +Germinal Center Derived <span class="nocase">B-cell</span> Lymphomas.” |
|
| 204 | +*Leukemia* 35 (7): 2002–16. |
|
| 205 | +<https://doi.org/10.1038/s41375-021-01251-z>. |
|
| 206 | + |
|
| 207 | +</div> |
|
| 208 | + |
|
| 209 | +<div id="ref-khodabakhshiRecurrentTargetsAberrant2012" |
|
| 210 | +class="csl-entry"> |
|
| 211 | + |
|
| 212 | +Khodabakhshi, Alireza Hadj, Ryan D. Morin, Anthony P. Fejes, Andrew J. |
|
| 213 | +Mungall, Karen L. Mungall, Madison Bolger-Munro, Nathalie A. Johnson, et |
|
| 214 | +al. 2012. “Recurrent Targets of Aberrant Somatic Hypermutation in |
|
| 215 | +Lymphoma.” *Oncotarget* 3 (11): 1308–19. |
|
| 216 | +<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717795/>. |
|
| 217 | + |
|
| 218 | +</div> |
|
| 219 | + |
|
| 220 | +<div id="ref-krysiakRecurrentSomaticMutations2017b" class="csl-entry"> |
|
| 221 | + |
|
| 222 | +Krysiak, Kilannin, Felicia Gomez, Brian S. White, Matthew Matlock, |
|
| 223 | +Christopher A. Miller, Lee Trani, Catrina C. Fronick, et al. 2017. |
|
| 224 | +“Recurrent Somatic Mutations Affecting <span |
|
| 225 | +class="nocase">B-cell</span> Receptor Signaling Pathway Genes in |
|
| 226 | +Follicular Lymphoma.” *Blood* 129 (4): 473–83. |
|
| 227 | +<https://doi.org/10.1182/blood-2016-07-729954>. |
|
| 228 | + |
|
| 229 | +</div> |
|
| 230 | + |
|
| 231 | +<div id="ref-lakeMutationsNFKBIAEncoding2009" class="csl-entry"> |
|
| 232 | + |
|
| 233 | +Lake, Annette, Lesley A. Shield, Pablo Cordano, Daniel T. Y. Chui, Julie |
|
| 234 | +Osborne, Shauna Crae, Katherine S. Wilson, et al. 2009. “Mutations of |
|
| 235 | +NFKBIA, Encoding IkappaB Alpha, Are a Recurrent Finding in Classical |
|
| 236 | +Hodgkin Lymphoma but Are Not a Unifying Feature of Non-<span |
|
| 237 | +class="nocase">EBV-associated</span> Cases.” *International Journal of |
|
| 238 | +Cancer* 125 (6): 1334–42. <https://doi.org/10.1002/ijc.24502>. |
|
| 239 | + |
|
| 240 | +</div> |
|
| 241 | + |
|
| 242 | +<div id="ref-lenzOncogenicCARD11Mutations2008" class="csl-entry"> |
|
| 243 | + |
|
| 244 | +Lenz, Georg, R Eric Davis, Vu N Ngo, Lloyd Lam, Thaddeus C George, |
|
| 245 | +George W Wright, Sandeep S Dave, et al. 2008. “Oncogenic CARD11 |
|
| 246 | +Mutations in Human Diffuse Large B Cell Lymphoma.” *Science* 319 (5870): |
|
| 247 | +1676–79. |
|
| 248 | + |
|
| 249 | +</div> |
|
| 250 | + |
|
| 251 | +<div id="ref-lohrDiscoveryPrioritizationSomatic2012a" class="csl-entry"> |
|
| 252 | + |
|
| 253 | +Lohr, Jens G., Petar Stojanov, Michael S. Lawrence, Daniel Auclair, |
|
| 254 | +Bjoern Chapuy, Carrie Sougnez, Peter Cruz-Gordillo, et al. 2012. |
|
| 255 | +“Discovery and Prioritization of Somatic Mutations in Diffuse Large |
|
| 256 | +<span class="nocase">B-cell</span> Lymphoma (DLBCL) by Whole-Exome |
|
| 257 | +Sequencing.” *Proceedings of the National Academy of Sciences of the |
|
| 258 | +United States of America* 109 (10): 3879–84. |
|
| 259 | +<https://doi.org/10.1073/pnas.1121343109>. |
|
| 260 | + |
|
| 261 | +</div> |
|
| 262 | + |
|
| 263 | +<div id="ref-louissaintPediatrictypeNodalFollicular2016a" |
|
| 264 | +class="csl-entry"> |
|
| 265 | + |
|
| 266 | +Louissaint, Abner, Kristian T. Schafernak, Julia T. Geyer, Alexandra E. |
|
| 267 | +Kovach, Mahmoud Ghandi, Dita Gratzinger, Christine G. Roth, et al. 2016. |
|
| 268 | +“Pediatric-Type Nodal Follicular Lymphoma: A Biologically Distinct |
|
| 269 | +Lymphoma with Frequent MAPK Pathway Mutations.” *Blood* 128 (8): |
|
| 270 | +1093–1100. <https://doi.org/10.1182/blood-2015-12-682591>. |
|
| 271 | + |
|
| 272 | +</div> |
|
| 273 | + |
|
| 274 | +<div id="ref-mareschalWholeExomeSequencing2016" class="csl-entry"> |
|
| 275 | + |
|
| 276 | +Mareschal, Sylvain, Sydney Dubois, Pierre-Julien Viailly, Philippe |
|
| 277 | +Bertrand, Elodie Bohers, Catherine Maingonnat, Jean-Philippe Jaïs, et |
|
| 278 | +al. 2016. “Whole Exome Sequencing of Relapsed/Refractory Patients |
|
| 279 | +Expands the Repertoire of Somatic Mutations in Diffuse Large <span |
|
| 280 | +class="nocase">B-cell</span> Lymphoma.” *Genes, Chromosomes & Cancer* 55 |
|
| 281 | +(3): 251–67. <https://doi.org/10.1002/gcc.22328>. |
|
| 282 | + |
|
| 283 | +</div> |
|
| 284 | + |
|
| 285 | +<div id="ref-morinSomaticMutationsAltering2010a" class="csl-entry"> |
|
| 286 | + |
|
| 287 | +Morin, Ryan D., Nathalie A. Johnson, Tesa M. Severson, Andrew J. |
|
| 288 | +Mungall, Jianghong An, Rodrigo Goya, Jessica E. Paul, et al. 2010. |
|
| 289 | +“Somatic Mutations Altering EZH2 (Tyr641) in Follicular and Diffuse |
|
| 290 | +Large <span class="nocase">B-cell</span> Lymphomas of Germinal-Center |
|
| 291 | +Origin.” *Nature Genetics* 42 (2): 181–85. |
|
| 292 | +<https://doi.org/10.1038/ng.518>. |
|
| 293 | + |
|
| 294 | +</div> |
|
| 295 | + |
|
| 296 | +<div id="ref-morinFrequentMutationHistonemodifying2011" |
|
| 297 | +class="csl-entry"> |
|
| 298 | + |
|
| 299 | +Morin, Ryan D., Maria Mendez-Lago, Andrew J. Mungall, Rodrigo Goya, |
|
| 300 | +Karen L. Mungall, Richard D. Corbett, Nathalie A. Johnson, et al. 2011. |
|
| 301 | +“Frequent Mutation of Histone-Modifying Genes in Non-Hodgkin Lymphoma.” |
|
| 302 | +*Nature* 476 (7360): 298–303. <https://doi.org/10.1038/nature10351>. |
|
| 303 | + |
|
| 304 | +</div> |
|
| 305 | + |
|
| 306 | +<div id="ref-morinMutationalStructuralAnalysis2013" class="csl-entry"> |
|
| 307 | + |
|
| 308 | +Morin, Ryan D., Karen Mungall, Erin Pleasance, Andrew J. Mungall, |
|
| 309 | +Rodrigo Goya, Ryan D. Huff, David W. Scott, et al. 2013. “Mutational and |
|
| 310 | +Structural Analysis of Diffuse Large <span class="nocase">B-cell</span> |
|
| 311 | +Lymphoma Using Whole-Genome Sequencing.” *Blood* 122 (7): 1256–65. |
|
| 312 | +<https://doi.org/10.1182/blood-2013-02-483727>. |
|
| 313 | + |
|
| 314 | +</div> |
|
| 315 | + |
|
| 316 | +<div id="ref-ngoOncogenicallyActiveMYD882011a" class="csl-entry"> |
|
| 317 | + |
|
| 318 | +Ngo, Vu N., Ryan M. Young, Roland Schmitz, Sameer Jhavar, Wenming Xiao, |
|
| 319 | +Kian-Huat Lim, Holger Kohlhammer, et al. 2011. “Oncogenically Active |
|
| 320 | +MYD88 Mutations in Human Lymphoma.” *Nature* 470 (7332): 115–19. |
|
| 321 | +<https://doi.org/10.1038/nature09671>. |
|
| 322 | + |
|
| 323 | +</div> |
|
| 324 | + |
|
| 325 | +<div id="ref-okosunRecurrentMTORC1activatingRRAGC2016a" |
|
| 326 | +class="csl-entry"> |
|
| 327 | + |
|
| 328 | +Okosun, Jessica, Rachel L. Wolfson, Jun Wang, Shamzah Araf, Lucy |
|
| 329 | +Wilkins, Brian M. Castellano, Leire Escudero-Ibarz, et al. 2016. |
|
| 330 | +“Recurrent <span class="nocase">mTORC1-activating RRAGC</span> Mutations |
|
| 331 | +in Follicular Lymphoma.” *Nature Genetics* 48 (2): 183–88. |
|
| 332 | +<https://doi.org/10.1038/ng.3473>. |
|
| 333 | + |
|
| 334 | +</div> |
|
| 335 | + |
|
| 336 | +<div id="ref-oricchioGeneticEpigeneticInactivation2017b" |
|
| 337 | +class="csl-entry"> |
|
| 338 | + |
|
| 339 | +Oricchio, Elisa, Natalya Katanayeva, Maria Christine Donaldson, |
|
| 340 | +Stephanie Sungalee, Joyce P. Pasion, Wendy Béguelin, Elena Battistello, |
|
| 341 | +et al. 2017. “Genetic and Epigenetic Inactivation of SESTRIN1 Controls |
|
| 342 | +<span class="nocase">mTORC1</span> and Response to EZH2 Inhibition in |
|
| 343 | +Follicular Lymphoma.” *Science Translational Medicine* 9 (396): |
|
| 344 | +eaak9969. <https://doi.org/10.1126/scitranslmed.aak9969>. |
|
| 345 | + |
|
| 346 | +</div> |
|
| 347 | + |
|
| 348 | +<div id="ref-pasqualucciInactivatingMutationsAcetyltransferase2011a" |
|
| 349 | +class="csl-entry"> |
|
| 350 | + |
|
| 351 | +Pasqualucci, Laura, David Dominguez-Sola, Annalisa Chiarenza, Giulia |
|
| 352 | +Fabbri, Adina Grunn, Vladimir Trifonov, Lawryn H. Kasper, et al. 2011. |
|
| 353 | +“Inactivating Mutations of Acetyltransferase Genes in <span |
|
| 354 | +class="nocase">B-cell</span> Lymphoma.” *Nature* 471 (7337): 189–95. |
|
| 355 | +<https://doi.org/10.1038/nature09730>. |
|
| 356 | + |
|
| 357 | +</div> |
|
| 358 | + |
|
| 359 | +<div id="ref-pasqualucciAnalysisCodingGenome2011" class="csl-entry"> |
|
| 360 | + |
|
| 361 | +Pasqualucci, Laura, Vladimir Trifonov, Giulia Fabbri, Jing Ma, Davide |
|
| 362 | +Rossi, Annalisa Chiarenza, Victoria A. Wells, et al. 2011. “Analysis of |
|
| 363 | +the Coding Genome of Diffuse Large <span class="nocase">B-cell</span> |
|
| 364 | +Lymphoma.” *Nature Genetics* 43 (9): 830–37. |
|
| 365 | +<https://doi.org/10.1038/ng.892>. |
|
| 366 | + |
|
| 367 | +</div> |
|
| 368 | + |
|
| 369 | +<div id="ref-pasqualucciHypermutationMultipleProtooncogenes2001a" |
|
| 370 | +class="csl-entry"> |
|
| 371 | + |
|
| 372 | +Pasqualucci, L., P. Neumeister, T. Goossens, G. Nanjangud, R. S. |
|
| 373 | +Chaganti, R. Küppers, and R. Dalla-Favera. 2001. “Hypermutation of |
|
| 374 | +Multiple Proto-Oncogenes in <span class="nocase">B-cell</span> Diffuse |
|
| 375 | +Large-Cell Lymphomas.” *Nature* 412 (6844): 341–46. |
|
| 376 | +<https://doi.org/10.1038/35085588>. |
|
| 377 | + |
|
| 378 | +</div> |
|
| 379 | + |
|
| 380 | +<div id="ref-reddyGeneticFunctionalDrivers2017" class="csl-entry"> |
|
| 381 | + |
|
| 382 | +Reddy, Anupama, Jenny Zhang, Nicholas S Davis, Andrea B Moffitt, |
|
| 383 | +Cassandra L Love, Alexander Waldrop, Sirpa Leppa, et al. 2017. “Genetic |
|
| 384 | +and Functional Drivers of Diffuse Large B Cell Lymphoma.” *Cell* 171 |
|
| 385 | +(2): 481–494.e15. |
|
| 386 | + |
|
| 387 | +</div> |
|
| 388 | + |
|
| 389 | +<div id="ref-russler-germainMutationsAssociatedProgression2023b" |
|
| 390 | +class="csl-entry"> |
|
| 391 | + |
|
| 392 | +Russler-Germain, David A., Kilannin Krysiak, Cody A. Ramirez, Matthew |
|
| 393 | +Mosior, Marcus P. Watkins, Felicia Gomez, Zachary L. Skidmore, et al. |
|
| 394 | +2023. “Mutations Associated with Progression in Follicular Lymphoma |
|
| 395 | +Predict Inferior Outcomes at Diagnosis: Alliance A151303.” *Blood |
|
| 396 | +Advances* 7: 5524–39. |
|
| 397 | +<https://doi.org/10.1182/bloodadvances.2023010779>. |
|
| 398 | + |
|
| 399 | +</div> |
|
| 400 | + |
|
| 401 | +<div id="ref-schmitzGeneticsPathogenesisDiffuse2018a" class="csl-entry"> |
|
| 402 | + |
|
| 403 | +Schmitz, Roland, George W. Wright, Da Wei Huang, Calvin A. Johnson, |
|
| 404 | +James D. Phelan, James Q. Wang, Sandrine Roulland, et al. 2018. |
|
| 405 | +“Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.” *The New |
|
| 406 | +England Journal of Medicine* 378 (15): 1396–1407. |
|
| 407 | +<https://doi.org/10.1056/NEJMoa1801445>. |
|
| 408 | + |
|
| 409 | +</div> |
|
| 410 | + |
|
| 411 | +<div id="ref-schollMutationsRegionFAS2007" class="csl-entry"> |
|
| 412 | + |
|
| 413 | +Scholl, Vanesa, Claudio Gustavo Stefanoff, Rocio Hassan, Nelson Spector, |
|
| 414 | +and Ilana Zalcberg Renault. 2007. “Mutations Within the 5’ Region of |
|
| 415 | +FAS/CD95 Gene in Nodal Diffuse Large <span class="nocase">B-cell</span> |
|
| 416 | +Lymphoma.” *Leukemia & Lymphoma* 48 (5): 957–63. |
|
| 417 | +<https://doi.org/10.1080/10428190701230858>. |
|
| 418 | + |
|
| 419 | +</div> |
|
| 420 | + |
|
| 421 | +<div id="ref-shinBRAFV600EMAP2K12015" class="csl-entry"> |
|
| 422 | + |
|
| 423 | +Shin, Sang-Yong, Seung-Tae Lee, Hee-Jin Kim, Chang-Seok Ki, Chul Won |
|
| 424 | +Jung, Jong-Won Kim, and Sun-Hee Kim. 2015. “BRAF V600E and MAP2K1 |
|
| 425 | +Mutations in Hairy Cell Leukemia and Splenic Marginal Zone Lymphoma |
|
| 426 | +Cases.” *Annals of Laboratory Medicine* 35 (2): 257–59. |
|
| 427 | +<https://doi.org/10.3343/alm.2015.35.2.257>. |
|
| 428 | + |
|
| 429 | +</div> |
|
| 430 | + |
|
| 431 | +<div id="ref-tanakaFrequentIncidenceSomatic1992" class="csl-entry"> |
|
| 432 | + |
|
| 433 | +Tanaka, S., D. C. Louie, J. A. Kant, and J. C. Reed. 1992. “Frequent |
|
| 434 | +Incidence of Somatic Mutations in Translocated BCL2 Oncogenes of |
|
| 435 | +Non-Hodgkin’s Lymphomas.” *Blood* 79 (1): 229–37. |
|
| 436 | + |
|
| 437 | +</div> |
|
| 438 | + |
|
| 439 | +<div id="ref-yildizActivatingSTAT6Mutations2015c" class="csl-entry"> |
|
| 440 | + |
|
| 441 | +Yildiz, Mehmet, Hongxiu Li, Denzil Bernard, Nisar A. Amin, Peter |
|
| 442 | +Ouillette, Siân Jones, Kamlai Saiya-Cork, et al. 2015. “Activating STAT6 |
|
| 443 | +Mutations in Follicular Lymphoma.” *Blood* 125 (4): 668–79. |
|
| 444 | +<https://doi.org/10.1182/blood-2014-06-582650>. |
|
| 445 | + |
|
| 446 | +</div> |
|
| 447 | + |
|
| 448 | +<div id="ref-zhangGeneticHeterogeneityDiffuse2013" class="csl-entry"> |
|
| 449 | + |
|
| 450 | +Zhang, Jenny, Vladimir Grubor, Cassandra L Love, Anjishnu Banerjee, |
|
| 451 | +Kristy L Richards, Piotr A Mieczkowski, Cherie Dunphy, et al. 2013. |
|
| 452 | +“Genetic Heterogeneity of Diffuse Large <span |
|
| 453 | +class="nocase">B-cell</span> Lymphoma.” January. |
|
| 454 | + |
|
| 455 | +</div> |
|
| 456 | + |
|
| 457 | +</div> |